Related Experiment Video
Updated: Jul 17, 2026
10:32
Hippocampal Insulin Microinjection and In vivo Microdialysis During Spatial Memory Testing
Published on: January 11, 2013
Hippocampal hypometabolism predicts cognitive decline from normal aging.
Lisa Mosconi1, Susan De Santi, Juan Li
1New York University School of Medicine, New York, NY 10016, USA.
Neurobiology of Aging
|January 16, 2007
Summary
Reduced glucose metabolism in the hippocampus during normal aging, detected by FDG-PET scans, can predict future cognitive decline and dementia years before clinical diagnosis.
Area of Science:
- Neuroimaging
- Gerontology
- Metabolic Brain Imaging
Background:
- Cognitive decline in aging is a growing concern.
- Early detection of neurodegenerative changes is crucial for timely intervention.
- FDG-PET imaging offers a metabolic window into brain function.
Purpose of the Study:
- To investigate FDG-PET's utility in predicting cognitive decline in normal aging.
- To monitor changes in glucose metabolism over time.
- To correlate metabolic changes with clinical progression to dementia.
Main Methods:
- Longitudinal study of 77 healthy elderly individuals (50-80 years old).
- Baseline and follow-up FDG-PET scans to measure glucose metabolic rates (MRglc).
- Clinical examinations over 6-14 years to assess cognitive status.
Main Results:
- Baseline hippocampal MRglc accurately predicted progression to Alzheimer's disease (81%) and mild cognitive impairment (71%).
- Declining individuals showed greater rates of hippocampal and cortical MRglc reduction.
- Dementia developed in 11 participants, and 19 progressed to MCI, on average 8 years post-scan.
Conclusions:
- FDG-PET's assessment of hippocampal metabolism predicts cognitive decline years before diagnosis.
- This metabolic marker aids in the early identification of individuals at risk.
- Further research is needed to enhance specificity for differentiating dementia subtypes.
Related Concept Videos
01:19Role of Hippocampus in Memory
The hippocampus, a critical brain structure, plays an essential role in memory processing, particularly in the formation and retrieval of memory. This small, seahorse-shaped region is located within the medial temporal lobe, with one hippocampus in each brain hemisphere. Experimental studies involving lesions in the hippocampi of rats have demonstrated significant impairments in tasks such as object recognition and maze navigation, indicating the hippocampus involvement in both recognition and...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:30Cognitive Development During Adulthood
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...